Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 16;20(12):2943.
doi: 10.3390/ijms20122943.

Interactions of Glutamatergic Neurotransmission and Brain-Derived Neurotrophic Factor in the Regulation of Behaviors after Nicotine Administration

Affiliations
Review

Interactions of Glutamatergic Neurotransmission and Brain-Derived Neurotrophic Factor in the Regulation of Behaviors after Nicotine Administration

Jieun Kim et al. Int J Mol Sci. .

Abstract

Nicotine causes tobacco dependence, which may result in fatal respiratory diseases. The striatum is a key structure of forebrain basal nuclei associated with nicotine dependence. In the striatum, glutamate release is increased when α7 nicotinic acetylcholine receptors expressed in the glutamatergic terminals are exposed to nicotine, and over-stimulates glutamate receptors in gamma amino-butyric acid (GABA)ergic neurons. These receptor over-stimulations in turn potentiate GABAergic outputs to forebrain basal nuclei and contribute to the increase in psychomotor behaviors associated with nicotine dependence. In parallel with glutamate increases, nicotine exposure elevates brain-derived neurotrophic factor (BDNF) release through anterograde and retrograde targeting of the synapses of glutamatergic terminals and GABAergic neurons. This article reviews nicotine-exposure induced elevations of glutamatergic neurotransmission, the bidirectional targeting of BDNF in the striatum, and the potential regulatory role played by BDNF in behavioral responses to nicotine exposure.

Keywords: TrkB; glutamate receptor; neurotrophic factor; nicotine dependence; striatum.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Changes in glutamatergic neurotransmission, bidirectional BDNF release, BDNF-mediated signaling cascades, and behavioral sensitization after repeated exposure to nicotine and nicotine withdrawal. (B,C) Proposed cellular mechanisms underlying repeated nicotine exposure and nicotine withdrawal mediated effects in GABAergic neurons are schematically depicted and compared. Exogenous BDNF infusion into the striatum during nicotine withdrawal returned hypoactivated GABAergic neurons to the basal level by activating TrkB-linked signaling cascades [91,96,97]. Switched neural activity caused by BDNF does not alter after challenge nicotine administration. Putative interactions are discussed in the text. Solid and broken arrows represent direct and indirect stimulations of downstream molecules or behaviors, respectively. AP, action potential; [Ca2+], Ca2+ concentration; EPSP, excitatory postsynaptic potential; IP3R, inositol trisphosphate receptor; mV, membrane potential; [Na+], Na+ concentration; PKC, protein kinase C; RyR, ryanodine receptor; SYT, synpatotagamin; tPAs, tissue-plasminogen activators; VGCC, voltage-gated calcium channel.

Similar articles

Cited by

References

    1. Rigotti N.A. Smoking cessation in patients with respiratory disease: Existing treatments and future directions. Lancet Respir. Med. 2013;3:241–250. doi: 10.1016/S2213-2600(13)70063-8. - DOI - PubMed
    1. Capelletto E., Rapetti S.G., Demichelis S., Galetta D., Catino A., Ricci D., Moretti A.M., Bria E., Pilotto S., Bruno A., et al. Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory disease. Clin. Respir. J. 2018;3:1150–1159. doi: 10.1111/crj.12644. - DOI - PubMed
    1. Grady S.R., Salminen O., Laverty D.C., Whiteaker P., McIntosh J.M., Collins A.C., Marks M.J. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem. Pharmacol. 2007;8:1235–1246. doi: 10.1016/j.bcp.2007.07.032. - DOI - PMC - PubMed
    1. Livingstone P.D., Wonnacott S. Nicotinic acetylcholine receptors and the ascending dopamine pathways. Biochem. Pharmacol. 2009;7:744–755. doi: 10.1016/j.bcp.2009.06.004. - DOI - PubMed
    1. Feduccia A.A., Chatterjee S., Bartlett S.E. Neuronal nicotinic acetylcholine receptors: Neuroplastic changes underlying alcohol and nicotine addictions. Front. Mol. Neurosci. 2012;5:83. doi: 10.3389/fnmol.2012.00083. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources